These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1440484)

  • 1. Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement: a randomised double-blind trial reported in conjunction with an overview of previous results.
    Gallus AS; Cade JF; Mills KW; Murphy W
    Thromb Haemost; 1992 Sep; 68(3):238-44. PubMed ID: 1440484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Sasahara AA
    Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of deep venous thrombosis following total hip replacement, using epidural analgesia.
    Christensen SW; Wille-Jørgensen P; Bjerg-Nielsen A; Kjaer L
    Acta Orthop Belg; 1989; 55(1):58-61. PubMed ID: 2801064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of heparin-dihydergot in the prevention of thromboembolic complications].
    Kuster B; Gruber UF
    Schweiz Med Wochenschr; 1984 Mar; 114(10):322-32. PubMed ID: 6369529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
    Adolf J; Fritsche HM; Haas S; Hennig FF; Horbach T; Kastl S; Koppenhagen K; Michaelis HC; Rhamanzadeh R; Summa W; Wagner W; Weber U; Wolf H
    Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine.
    Alfaro MJ; Páramo JA; Rocha E
    Thromb Haemost; 1986 Aug; 56(1):53-6. PubMed ID: 3535158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine.
    Haas S; Stemberger A; Fritsche HM; Welzel D; Wolf H; Lechner F; Blümel G
    Arzneimittelforschung; 1987 Jul; 37(7):839-43. PubMed ID: 2823840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in hip joint surgery].
    Liedloff H; Brauckhoff KF; Heerdegen R; Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):428-31. PubMed ID: 6390998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of postoperative thrombotic complications with heparin and dihydroergotamine. A randomized double-blind study].
    Breddin K; Häring R; Koppenhagen K
    Dtsch Med Wochenschr; 1983 Jan; 108(3):98-102. PubMed ID: 6337038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and side effects of low-molecular weight heparin-dihydroergotamine in preventing thromboembolism in abdominal surgery].
    Voigt J; Hamelmann H; Hedderich J; Seifert J; Buchhammer T; Köhler A
    Zentralbl Chir; 1986; 111(21):1269-305. PubMed ID: 3544605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery.
    Lahnborg G
    Acta Chir Scand; 1980; 146(5):319-22. PubMed ID: 7468062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of preoperative blood tests for predicting deep vein thrombosis after total hip replacement.
    Mindner K; Bergmann I; Sturm G; Liedloff H; Hindersin P; Gleiser W; Till U; Vogel G
    Haematologia (Budap); 1988; 21(1):47-55. PubMed ID: 3396975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial.
    Huo MH; Salvati EA; Sharrock NE; Brien WW; Sculco TP; Pellicci PM; Mineo R; Go G
    Clin Orthop Relat Res; 1992 Jan; (274):35-46. PubMed ID: 1729021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
    Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative changes in hemostasis by heparin/dihydroergotamine prevention].
    Briel RC
    Fortschr Med; 1983 May; 101(18):846-9. PubMed ID: 6862345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.